definiens: shall mean any invention or discovery created or otherwise Controlled by [COMPANY] orBellicum during the period from the Original Effective Date through the end of the Term, which constitutes anenhancement or modification of any invention within the Licensed Technology or Licensed Patent Rights, togetherwith the Patent Rights and Technology that claim or cover such invention or discovery ; provided, however, thatImprovement does not include ( a ) any Antigen or Inducible Co - Stimulatory Molecule, ( b ) any product ( or treatmentregime or process using a product ), comprising ( i ) a dendritic cell transfected with both a gene for any Antigen, apeptide or a protein that is an Antigen or an RNA that induces the Portions of this Exhibit, indicated by the mark were omitted and have been filed separately with the Securitiesand Exchange Commission pursuant to the Registrant ’s application requesting confidential treatment pursuant toRule 24b-2 of the Securities Exchange Act of 1934, as amended